# AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function

> **NCT05432765** · NA · NOT_YET_RECRUITING · sponsor: **University of Florida** · enrollment: 34 (estimated)

## Conditions studied

- Kidney Transplant Rejection

## Interventions

- **OTHER:** Phenotypic Personalized Medicine Dosing
- **OTHER:** Standard of Care Dosing

## Key facts

- **NCT ID:** NCT05432765
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12
- **Primary completion:** 2030-08-12
- **Final completion:** 2031-01-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05432765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05432765, "AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT05432765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*